DELOR 0.05% Ointment Price, Uses, Alternatives, Dose, and more in UAE 2023
DELOR 0.05% Ointment
361
AED 11
Drug name DELOR 0.05%
Active substance Clobetasol propionate
Size : 25g Collapsible Tube
Concentration: 0.5mg/g
Type: Ointment
Company : PHARMA INTERNATIONAL CO.
Import: JORDAN
Uploaded By : Admin
ٍ Visits : 361 visit
Delore scientific name
Clobetasol propionate
What is Dilor medication?
Clobetasol is a powerful steroid, a derivative of prednisolone.
Helps skin absorption, as a topical treatment for psoriasis.
What are the uses of Dilor?
Topical treatment of inflammation and itching caused by a number of skin diseases such as: allergies, eczema, and psoriasis.
What are the contraindications of using Dilor?
It is forbidden to use Clobetasol without consulting a specialist in cases of allergy to any of the components of the drug.
Clobetasol for children
Clobetasol should not be used in children under 12 years of age.
What are the precautions for using Dilor?
Clobetasol should be used with caution under the supervision of a doctor in the following cases:
young love.
Skin cuts, injuries, or cuts.
Clobetasol for diabetes
Clobetasol should be used with caution in patients with diabetes, as it increases the level of sugar in the blood and urine.
Clobetasol for pregnant or breastfeeding women
Clobetazole should be used during pregnancy and lactation with caution and only if the expected benefits outweigh the risks, due to insufficient research on the drugs passage to the fetus or infant through breast milk.
What are the drug interactions of Dilor?
It is preferable to tell the doctor or pharmacist about all medications, herbs, vitamins, and nutritional supplements before starting treatment.
It is recommended that topical ointments and Clobetasol be separated by 2 hours.
It should not be combined with other steroid creams, to avoid side effects.
What are Dilor doses and methods of use?
Apply a thin layer of clobetazole over the affected area twice a day.
Welcome to Dwaey, specifically on DELOR 0.05% Ointment page.
This medicine contains an important and useful components, as it consists of Clobetasol propionate.
DELOR 0.05% is available in the market in concentration 0.5mg/g and in the form of Ointment.
PHARMA INTERNATIONAL CO. is the producer of DELOR 0.05% and it is imported from JORDAN.
The most popular alternatives of DELOR 0.05% are listed downward .
Lets know how to use DELOR 0.05% Ointment
Childn <12 yrs. Long-term treatment of ulcerative conditions, rosacea, pruritus; It is contraindicated in rosacea, acne vulgaris, perioral dermatitis, primary cutaneous viral infections (eg. herpes simplex, chickenpox), otitis externa with a perforated eardrum, hypersensitivity to the preparations. Scalp application is contraindicated in infection of the scalp.
Long-term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If used in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important. Scalp Application: Keep away from eye. Flammable. Do not use or dry the hair near a fire or flame. Scalp Shampoo: Do not use on areas other than the scalp. Keep away from eye. Lactation: Excretion in milk unknown; use with caution
Clobetasol is a very potent corticosteroid used in short-term treatment of various inflammatory skin conditions. Corticosteroids decrease inflammation by stabilizing leukocyte lysosomal membranes, preventing release of destructive acid hydrolases from leukocytes; inhibiting macrophage accumulation in inflamed areas; reducing leukocyte adhesion to capillary endothelium; reducing capillary wall permeability and edema formation; decreasing complement components; antagonizing histamine activity and release of kinin from substrates; and reducing fibroblast proliferation, collagen deposition, and subsequent scar tissue formation.
Increased systemic exposure w/ CYP3A4 inhibitors (eg ritonavir & itraconazole).